BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16301573)

  • 1. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
    Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
    J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Manfredi MJ; Sorenmo KU
    Vet Pathol; 2005 May; 42(3):350-3. PubMed ID: 15872381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase-2 in canine nasal carcinomas.
    Impellizeri JA; Esplin DG
    Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
    Borzacchiello G; Russo V; Russo M
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Millanta F; Citi S; Della Santa D; Porciani M; Poli A
    Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.
    Smith KM; Scase TJ; Miller JL; Donaldson D; Sansom J
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():8-14. PubMed ID: 19046264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
    Brunelle M; Sartin EA; Wolfe LG; Sirois J; Doré M
    Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
    Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
    Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
    Queiroga FL; Pires I; Lobo L; Lopes CS
    Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression in canine mammary tumors.
    Doré M; Lanthier I; Sirois J
    Vet Pathol; 2003 Mar; 40(2):207-12. PubMed ID: 12637762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance.
    Queiroga FL; Perez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    Anticancer Res; 2005; 25(6B):4269-75. PubMed ID: 16309227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
    Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
    Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression in canine anal sac adenocarcinomas and in non-neoplastic canine anal sacs.
    Knudsen CS; Williams A; Brearley MJ; Demetriou JL
    Vet J; 2013 Sep; 197(3):782-7. PubMed ID: 23778258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.